EMA warns Pacira about manufacturing deficiencies
The EMA has warned Pacira Pharmaceuticals about a number of manufacturing deficiencies following an inspection of the firm’s plant in the US.
The EMA has warned Pacira Pharmaceuticals about a number of manufacturing deficiencies following an inspection of the firm’s plant in the US.
The US FDA plans to establish a new database for manufacturing facilities required to ‘self-identify’ under new GDUFA laws.
India’s IT sector must expand its knowledge base to fully meet the surge in demand for biostatistics says Alticure Research.
US Injectable drugmaker Hospira will invest $85m and create 200 new jobs at its plant in Rocky Mount, North Carolina according to the State Governor.
Precos will expand its portfolio of preclinical cancer models after being licensed to store and handle human tissue by the UK’s HTA.